Masimo
Masimo's O3 Regional Oximeter can be integrated with its SedLine brain function monitor or its Root patient monitoring and connectivity platform.
The device applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and opioid withdrawal symptoms.
The new technology will be integrated into the connected MightSat Rx finger pulse oximeter.
Also: Dictum Health's Lebanese pilot; New data on NeuroMetrix's Quell.
The eight devices will receive increased guidance and interaction for their clearance efforts, and some will receive Breakthrough Device designation.
Masimo's acoustic respiration sensor, the RAS-45 for Rainbow Acoustic Monitoring, is clearedfor use among infants and neotal patients 10kg and under.